Application of Eudragit RS 30D as a Potential Drug Release Retardant of Acetaminophen and Caffeine for Prolonged Duration of Comfort
The objective of the study is to formulate an extended release matrix tablet dosage form containing acetaminophen and caffeine by applying polymer technology which will relieve all kinds of pain for about 12 hours. Considering the fact that there is no such formulation available in the pharmaceutica...
Saved in:
Main Authors: | Lailoona Jaweed, Huma Dilshad, Ghulam Sarwar |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-01-01
|
Series: | International Journal of Polymer Science |
Online Access: | http://dx.doi.org/10.1155/2019/3830670 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Development of Duloxetine Hydrochloride Tablets for Delayed and Complete Release Using Eudragit L 100
by: M. Yasmin Begum, et al.
Published: (2021-01-01) -
Modified release of furosemide from Eudragits® and poly(ethylene oxide)-based matrices and dry-coated tablets
by: Vlachou Marilena, et al.
Published: (2020-03-01) -
Investigation of in situ gelling alginate formulations as a sustained release vehicle for co-precipitates of dextromethrophan and Eudragit S 100
by: Maghraby Gamal Mohamed El, et al.
Published: (2014-03-01) -
Mathematical Modelling of Acetaminophen Release in HPC/PAAm Hydrogel: Synthesis and Application
by: Abigail M. Díaz-Guerrero, et al.
Published: (2019-01-01) -
Impact of Additives on Heterogeneous Crystallization of Acetaminophen
by: Hsinyun Hsu, et al.
Published: (2018-01-01)